TRCT
PTX

Tower Research Capital (TRC)’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,236
Closed -$5K – 4458
2017
Q2 		$5K Buy
1,236
+608
+97% +$2.65K ﹤0.01% 2060
2017
Q1 		$2K Buy
+628
New +$1.97K ﹤0.01% 2742
2016
Q3 		– Sell
-1,469
Closed -$7K – 5168
2016
Q2 		$7K Buy
+1,469
New +$9.59K ﹤0.01% 3221
2016
Q1 		– Sell
-30
Closed -$596 – 5578
2015
Q4 		$1K Sell
30
-507
-94% -$15.3K ﹤0.01% 4318
2015
Q3 		$17K Sell
537
-845
-61% -$40.4K ﹤0.01% 1910
2015
Q2 		$82K Buy
+1,382
New +$97.5K 0.01% 1004
2015
Q1 		– Sell
-803
Closed -$75K – 5328
2014
Q4 		$75K Buy
803
+631
+367% +$60.2K 0.01% 846
2014
Q3 		$13K Sell
172
-445
-72% -$35K ﹤0.01% 2672
2014
Q2 		$56K Buy
617
+132
+27% +$8.09K 0.01% 1230
2014
Q1 		$26K Buy
+485
New +$16K ﹤0.01% 1666
2013
Q4 		– Sell
-8
Closed – – 5240
2013
Q3 		$0 Sell
8
-292
-97% -$9.4K ﹤0.01% 5084
2013
Q2 		$11K Buy
+300
New +$11.2K ﹤0.01% 2328

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Research Capital (TRC)'s PTX Position: Q3 2017 in Review

Tower Research Capital (TRC) sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2017, closing a stake of 1,236 shares — an estimated $5K sold.

Tower Research Capital (TRC) first reported a position in PTX in Q2 2013 and held it in 12 quarters. The position peaked at $82K in Q2 2015. 32 funds tracked by Wall St. Rank hold PTX as of Q3 2017.

  • Tower Research Capital (TRC) reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,236 Pernix Therapeutics Holdings, Inc. shares in Q3 2017, an estimated $5K.
  • Tower Research Capital (TRC) first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Pernix Therapeutics Holdings, Inc. position peaked at $82K in Q2 2015.
  • 32 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.